ArticleBMC women's health2026
Evaluation of salivary bone turnover markers and vitamin D as non-invasive, early predictive indicators of bone health in pre-, peri-, and post-menopausal women.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMenopause adversely affects bone health, often going unnoticed. Salivary biomarkers may provide a non-invasive approach to assess bone turnover and oral health changes across menopausal stages.
aimTo evaluate salivary bone turnover markers—alkaline phosphatase (ALP), osteocalcin, and vitamin D3—in pre-, peri, and postmenopausal women, and explore their association with oral health.
methodsA cross-sectional study was conducted among 150 women: premenopausal (n = 50), perimenopausal (n = 50), and postmenopausal (n = 50). Salivary ALP, osteocalcin, and vitamin D3 were measured using Enzyme linked immuno sorbent assay (ELISA). Oral health status was assessed through hard tissue changes (decayed, missing, calculus and mobility) and soft tissue changes. Salivary calcium and phosphorus levels were also estimated.
resultsPostmenopausal women showed significantly lower salivary osteocalcin (685.16 ± 248.91; 855.87 ± 351.39; cohens d = 0.56;p < 0.05)and vitamin D3 (137.35 ± 58.34;110 ± 45.6; cohens d = 0.52;p < 0.01)compared to perimenopausal women, while ALP levels did not differ significantly among peri (10.54 ± 2.58)and postmenopausal group(8.95 ± 3.94; cohens d = 0.48;p = 0.09). Salivary calcium and phosphorus were reduced in peri- and postmenopausal women(p < 0.001). Poor oral health correlated positively with duration of menopause(r = 0.7;p = 0.0038), whereas vitamin D3 showed a negative correlation(r=-0.6; p = 0.0038).
conclusionSalivary vitamin D3 and osteocalcin, along with oral tissue changes, vary significantly with menopausal stage, while ALP remains unchanged. These findings highlight the potential of salivary biomarkers as early, non-invasive indicators for detecting bone loss and mitigating postmenopausal health consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.